Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Liu

Showing results (461-470 of 574) with videos related to

Pageof 58
Sort By:
BMC Medicine|January 31, 2022
Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomizationMark Gormley, Tom Dudding, Linda Kachuri, et al.
Ebiomedicine|June 4, 2018
Multi-Omics Analysis Reveals a HIF Network and Hub Gene EPAS1 Associated with Lung AdenocarcinomaZhaoxi Wang, Yongyue Wei, Ruyang Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|December 17, 2025
Corrigendum to "Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)" [Lung Cancer 210 (2025) 108840]William J Phillips, Luna Jia Zhan, Deepro Chowdhury, et al.
Lung Cancer (Amsterdam, Netherlands)|November 22, 2025
Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)William J Phillips, Luna Jia Zhan, Deepro Chowdhury, et al.
JTO Clinical and Research Reports|August 19, 2024
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLCWilliam Tompkins, Connor B Grady, Wei-Ting Hwang, et al.
Human Molecular Genetics|July 20, 2023
Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer riskJennifer Luyapan, Yohan Bossé, Zhonglin Li, et al.
Canadian Journal of Kidney Health and Disease|November 25, 2021
A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research ProtocolAnshika Jain, Ryan Huang, Jasmine Lee, et al.
JTO Clinical and Research Reports|January 6, 2025
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry AnalysisMargaret Stalker, Connor B Grady, Alex Watts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2017
Common <i>TDP1</i> Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer ConsortiumPawadee Lohavanichbutr, Lori C Sakoda, Christopher I Amos, et al.
Lung Cancer (Amsterdam, Netherlands)|April 22, 2025
Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysisAdam Barsouk, Omar Elghawy, Alex Watts, et al.
Pageof 58

Showing results (461-470 of 574) with videos related to

Sort By:
Pageof 58
BMC Medicine|January 31, 2022
Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomizationMark Gormley, Tom Dudding, Linda Kachuri, et al.
Ebiomedicine|June 4, 2018
Multi-Omics Analysis Reveals a HIF Network and Hub Gene EPAS1 Associated with Lung AdenocarcinomaZhaoxi Wang, Yongyue Wei, Ruyang Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|December 17, 2025
Corrigendum to "Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)" [Lung Cancer 210 (2025) 108840]William J Phillips, Luna Jia Zhan, Deepro Chowdhury, et al.
Lung Cancer (Amsterdam, Netherlands)|November 22, 2025
Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)William J Phillips, Luna Jia Zhan, Deepro Chowdhury, et al.
JTO Clinical and Research Reports|August 19, 2024
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLCWilliam Tompkins, Connor B Grady, Wei-Ting Hwang, et al.
Human Molecular Genetics|July 20, 2023
Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer riskJennifer Luyapan, Yohan Bossé, Zhonglin Li, et al.
Canadian Journal of Kidney Health and Disease|November 25, 2021
A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research ProtocolAnshika Jain, Ryan Huang, Jasmine Lee, et al.
JTO Clinical and Research Reports|January 6, 2025
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry AnalysisMargaret Stalker, Connor B Grady, Alex Watts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2017
Common <i>TDP1</i> Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer ConsortiumPawadee Lohavanichbutr, Lori C Sakoda, Christopher I Amos, et al.
Lung Cancer (Amsterdam, Netherlands)|April 22, 2025
Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysisAdam Barsouk, Omar Elghawy, Alex Watts, et al.
Pageof 58